drugsScienceA Pill Version of Ozempic Is ComingBy Emily MullinIdeasTo Combat the Overdose Crisis, Expand Drug-Checking ProgramsBy Abdullah Shihipar and Alexandra CollinsIdeasScientists Gave People Psychedelics—and Then Erased Their MemoryBy Shayla LoveSecurityChinese Labs Are Selling Fentanyl Ingredients for Millions in CryptoBy Andy GreenbergScienceInside the Secretive Life-Extension ClinicBy Frank SwainScienceThe Supreme Court Preserves Abortion Pill Access—TemporarilyBy Emily MullinScienceThe Supreme Court Has Delayed Its Abortion Pill DecisionBy Emily MullinScienceThe US Supreme Court Restores Access to Abortion Pills—for NowBy Emily MullinScienceThe Abortion Pill Legal Standoff Endangers Access to All DrugsBy Emily Mullin and Maryn McKennaScienceThe Therapy Part of Psychedelic Therapy Is a MessBy Grace BrowneThe Big StoryOn the Trail of the Fentanyl KingBy Benoît MorenneThe Big StoryThis Is a Philosopher on DrugsBy Justin Smith-RuiuIdeasThe Future of Weight Loss Looks a Lot Like Its PastBy Eleanor CumminsScienceA Novel Male Birth Control Could Be an ‘On-Off Switch for Sperm’By Emily MullinScienceSchizophrenia Drugs Are Finally Getting an OverhaulBy Grace BrowneScienceA Crucial Group of Covid Drugs Has Stopped WorkingBy Emily MullinScienceMDMA and Psilocybin Are Approved as Medicines for the First TimeBy Grace BrowneScienceThe US Just Greenlit High-Tech Alternatives to Animal TestingBy Emily MullinScienceDrug Shortages Aren’t New. The Tripledemic Just Made You LookBy Maryn McKennaIdeasA Drug to Treat Aging May Not Be a Pipe DreamBy Andrew SteeleCultureThe Next Great Overdose-Reversing Drug Might Already ExistBy Kate KnibbsScienceThe Amyloid Debate Has No Easy Answers for Alzheimer’s ScientistsBy Grace HuckinsScienceThe Harms of Psychedelics Need to Be Put Into ContextBy Grace BrowneIdeasSeeking Psychedelics? Check the Data Privacy ClauseBy Mason MarksMore Stories
.jpg)
